Immunomedics Up 5% After Announcing Its New Studies About Development Of Cancer Products April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Robert Fuller Immunomedics Up 5% After Announcing Its New Studies About Development Of Cancer Products.
